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*Lactobacillus* is the largest and most diverse genus among the lactic acid bacteria (LAB) ([@B1], [@B2]). Their natural habitat ranges from fermented dairy, meat, and plant products to the oral cavity, intestinal, and vaginal tracts of humans and animals ([@B1], [@B3], [@B4]). The genotypic and phenotypic diversity of LAB was acquired by gain of functions through horizontal gene transfer (HGT) from other LAB and loss of dispensable ancestral functions ([@B1], [@B5]). Mobile genetic elements such as insertion sequences and phages play an important role in HGT ([@B1], [@B6]).

*Lactobacillus curvatus* is a LAB that is most commonly associated with fermented products ([@B7], [@B8]). *L. curvatus* FBA2 (FBA2) examined herein was isolated from radish and carrot pickled with rice bran and salt ([@B9]). FBA2 was selected from 200 strains of LAB as a strain that enhanced the expression level of type I collagen and hyaluronan in human dermal fibroblasts. FBA2 improved moisture and elasticity of the skin of hairless mice, which were fed a low protein diet, and increased collagen peptide uptake in rat intestine ([@B9][@B10][@B12]). Use of FBA2 in skin-improving products was patented, and some food products containing FBA2 are commercialized in Japan ([@B12]).

Genomic information is the key to clarifying potential functions of *L. curvatus*; however, its complete genome sequence is not publicly available yet (<http://www.ncbi.nlm.nih.gov/genome/genomes/10762>). One of the four scaffold-level sequences, *L. curvatus* JCM 1096, has been determined using Ion PGM in 72 contigs (BBBQ01000000) (total 1,814,792 bp; average G+C content of 41.8%) ([@B2], [@B7], [@B8]). Here, we report the first complete genome sequence of *L. curvatus*, strain FBA2, determined by the single-molecule real-time (SMRT) technology ([@B13]).

The genomic DNA was extracted at the early log phase and purified using a PowerClean DNA cleanup kit (MO BIO Laboratories, Carlsbad, CA), followed by 20-kb library construction for P6-C4 chemistry with shearing. Size selection was not performed. Eight SMRT cells (each 240-min movies) were sequenced using the PacBio RS II platform (Pacific Biosciences, Menlo Park, CA). *De novo* assembly was performed using the hierarchical genome assembly process (HGAP) version 2 ([@B14]). A single circular contig representing one chromosome (1,848,756 bp, G+C content of 42.1%, and 1,847× coverage) was obtained. No plasmids were detected by assembly or gel electrophoresis, indicating that FBA2 does not include plasmids. The genome contained 43 sets of \>1,000-bp identical sequence pairs (3,118-bp maximum), including 22 insertion sequences, low G+C regions (2,000 bp, G+C content of 26.9% minimum), and five prophage sequences. Such regions are difficult to reconstruct by short-read sequencers with PCR amplification ([@B6], [@B15]). PacBio RS II produced reads with an average of 4,290 bp and a maximum of 43,302 bp with uniform coverage. Multi-kilobase reads and unbiased G+C coverage resolved \>1,000-bp identical sequence pairs and low G+C regions, respectively.

The complete genome sequence of *L. curvatus* FBA2 will help to elucidate the skin-improving mechanism of and the diversity among *L. curvatus*.
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The complete genome sequence of *L. curvatus* FBA2 has been deposited in DDBJ/ENA/GenBank under accession number [CP016028](http://www.ncbi.nlm.nih.gov/nuccore/CP016028).
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